Impact Of Bronchoscopy After First-Line Chemotherapy In Patients With Stage Iv Non Small Cell Lung Cancer On Overall Survival

被引：0
|
作者：
Dayen, C. [1 ]
Trouve, C. [1 ]
Poulet, C. [2 ]
Gubler, B.
Sevestre, H. [3 ]
Suguenot, R. [1 ]
Bentayeb, H. [1 ]
Rault, I. [1 ]
Lecuyer, E. [1 ]
Hoguet, E. [4 ]
Le Meunier, F. [1 ]
Jounieaux, V. [2 ]
Benzerdjeb, N. [3 ]
Andrejak, C. [1 ]
Douadi, Y. [1 ]
机构：
[1] CHG St Quentin, St Quentin en Yvelines, France
[2] Pneumol Unit, Amiens, France
[3] Pathol Unit, Amiens, France
[4] CH Abbeville, Pneumol Unit, Abbeville, France
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3397
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Chemotherapy beyond first-line in stage IV metastatic non-small cell lung cancer
    Younes, Riad Naim
    Pereira, Jost Rodrigues
    Fares, Abdo Latif
    Gross, Jefferson Luiz
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2011, 57 (06): : 686 - 691
  • [2] Relative dose intensity of first-line chemotherapy and overall survival in patients with advanced non-small-cell lung cancer
    Crawford, Jeffrey
    Denduluri, Neelima
    Patt, Debra
    Jiao, Xiaolong
    Morrow, Phuong Khanh
    Garcia, Jacob
    Barron, Richard
    Lyman, Gary H.
    SUPPORTIVE CARE IN CANCER, 2020, 28 (02) : 925 - 932
  • [3] Relative dose intensity of first-line chemotherapy and overall survival in patients with advanced non-small-cell lung cancer
    Jeffrey Crawford
    Neelima Denduluri
    Debra Patt
    Xiaolong Jiao
    Phuong Khanh Morrow
    Jacob Garcia
    Richard Barron
    Gary H. Lyman
    Supportive Care in Cancer, 2020, 28 : 925 - 932
  • [4] Irinotecan and docetaxel as first-line chemotherapy in patients with stage IIIB/IV non-small cell lung cancer.
    Raez, LE
    Rosado, M
    Santos, ES
    Hamilton, K
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 677S - 677S
  • [5] Postprogression survival for first-line chemotherapy of patients with advanced non-small-cell lung cancer
    Hayashi, H.
    Okamoto, I.
    Morita, S.
    Taguri, M.
    Nakagawa, K.
    ANNALS OF ONCOLOGY, 2012, 23 (06) : 1537 - 1541
  • [6] Relative Dose Intensity of First-Line Chemotherapy and Overall Survival in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC)
    Denduluri, Neelima
    Patt, Debra
    Jiao, Xiaolong
    Morrow, Phuong
    Garcia, Jacob
    Barron, Rich
    Crawford, Jeffrey
    Lymans, Gary
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S891 - S892
  • [7] Impact of Liver Metastasis on First-Line Immunotherapy in Stage IV Non-Small Cell Lung Cancer
    Komiya, Takefumi
    Takamori, Shinkichi
    Shimokawa, Mototsugu
    WORLD JOURNAL OF ONCOLOGY, 2023, 14 (04) : 234 - 245
  • [8] Clinical impact of post-progression survival on overall survival in patients with limited-stage disease small cell lung cancer after first-line chemoradiotherapy
    Kasahara, Norimitsu
    Imai, Hisao
    Kaira, Kyoichi
    Mori, Keita
    Wakuda, Kazushige
    Ono, Akira
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Harada, Hideyuki
    Naito, Tateaki
    Murakami, Haruyasu
    Endo, Masahiro
    Nakajima, Takashi
    Yamada, Masanobu
    Takahashi, Toshiaki
    RADIOLOGY AND ONCOLOGY, 2015, 49 (04) : 409 - 415
  • [9] First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer
    Carbone, D. P.
    Reck, M.
    Paz-Ares, L.
    Creelan, B.
    Horn, L.
    Steins, M.
    Felip, E.
    van den Heuvel, M. M.
    Ciuleanu, T. -E.
    Badin, F.
    Ready, N.
    Hiltermann, T. J. N.
    Nair, S.
    Juergens, R.
    Peters, S.
    Minenza, E.
    Wrangle, J. M.
    Rodriguez-Abreu, D.
    Borghaei, H.
    Blumenschein, G. R.
    Villaruz, L. C.
    Havel, L.
    Krejci, J.
    Corral Jaime, J.
    Chang, H.
    Geese, W. J.
    Bhagavatheeswaran, P.
    Chen, A. C.
    Socinski, M. A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (25): : 2415 - 2426
  • [10] Circulating metabolite profiles to predict overall survival in advanced non-small cell lung cancer patients receiving first-line chemotherapy
    Shen, Jie
    Ye, Yuanqing
    Chang, David W.
    Huang, Maosheng
    Heymach, John V.
    Roth, Jack A.
    Wu, Xifeng
    Zhao, Hua
    LUNG CANCER, 2017, 114 : 70 - 78
12345